< Back to previous page


Single domain antibodies against SOD1 and their use in medicine

The present application relates to the field of single-domain antibodies (also called nanobodies), more particularly single-domain antibodies against SOD1 protein isoforms. It also relates to the use of these nanobodies in medicine. Accordingly, methods to treat a disease using these nanobodies are provided herein. The single-domain antibodies are particularly envisaged for treatment of ALS.
Patent Publication Number: US9862777
Source: USPTO
Year filing: 2014
Year approval: 2018
Year publication: 2018
Status: Assigned
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven